AI can help care teams identify heart patients who would benefit from TAVR or another life-changing valve intervention.

Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.

Neurosurgeon Vitor Mendes Pereira, MD, was in Santiago, Panama, but his patient was in Panama City. "It is the highlight of my career to be involved in this historic achievement," Pereira said.

A multidisciplinary research team has found a new use for a reliable medical device. Multiple heart patients have already benefited for the group’s outside-the-box thinking.

The high-risk patients who require urgent or emergent TAVR are often excluded from major clinical trials. To learn more about this population, researchers explored data from nearly 600 patients treated at high-volume facilities. 

Meanwhile members of Gen Z are twice as likely as other generations to get sneaky about their use of medical AI. 

U.S. healthcare will know it’s gotten AI right when the technology demonstrably improves care access, attentiveness and outcomes for the least financially healthy among us. 

A new acellular tissue-engineered vessel developed by Vascudyne could provide surgeons with a safe, effective alternative to saphenous vein grafts.